362 related articles for article (PubMed ID: 24641589)
21. Probing Cellular Processes Using Engineered Nanoparticles.
Hossen MN; Murphy B; Garcı A-Hevia L; Bhattacharya R; Mukherjee P
Bioconjug Chem; 2018 Jun; 29(6):1793-1808. PubMed ID: 29742344
[TBL] [Abstract][Full Text] [Related]
22. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
23. Nanomaterials in combating cancer: therapeutic applications and developments.
Nazir S; Hussain T; Ayub A; Rashid U; MacRobert AJ
Nanomedicine; 2014 Jan; 10(1):19-34. PubMed ID: 23871761
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
Chen F; Hableel G; Zhao ER; Jokerst JV
J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
[TBL] [Abstract][Full Text] [Related]
25. Applications of upconversion nanoparticles in imaging, detection and therapy.
Ang LY; Lim ME; Ong LC; Zhang Y
Nanomedicine (Lond); 2011 Sep; 6(7):1273-88. PubMed ID: 21929461
[TBL] [Abstract][Full Text] [Related]
26. Carbon-based nanomaterials: multifunctional materials for biomedical engineering.
Cha C; Shin SR; Annabi N; Dokmeci MR; Khademhosseini A
ACS Nano; 2013 Apr; 7(4):2891-7. PubMed ID: 23560817
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles for biomedical imaging.
Nune SK; Gunda P; Thallapally PK; Lin YY; Forrest ML; Berkland CJ
Expert Opin Drug Deliv; 2009 Nov; 6(11):1175-94. PubMed ID: 19743894
[TBL] [Abstract][Full Text] [Related]
28. Advances in stimuli responsive nanobiomaterials for cancer therapy.
Sampathkumar K; Arulkumar S; Ramalingam M
J Biomed Nanotechnol; 2014 Mar; 10(3):367-82. PubMed ID: 24730233
[TBL] [Abstract][Full Text] [Related]
29. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
[TBL] [Abstract][Full Text] [Related]
30. Dendrimer-nanoparticle conjugates in nanomedicine.
Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy.
Aranda-Lara L; Morales-Avila E; Luna-Gutiérrez MA; Olivé-Alvarez E; Isaac-Olivé K
Chem Phys Lipids; 2020 Aug; 230():104934. PubMed ID: 32562666
[TBL] [Abstract][Full Text] [Related]
32. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
33. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
34. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
35. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
36. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
37. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
[TBL] [Abstract][Full Text] [Related]
38. Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?
Elinav E; Peer D
ACS Nano; 2013 Apr; 7(4):2883-90. PubMed ID: 23570555
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.
Szelenyi I
Inflamm Res; 2012 Jan; 61(1):1-9. PubMed ID: 22057873
[TBL] [Abstract][Full Text] [Related]
40. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
Tassa C; Shaw SY; Weissleder R
Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
